EUVIMEDEUVIMED entdecken
Open Access

Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistance

Erica C Larson iD, Amy L Ellis, Mark A Rodgers iD, Abigail K Gubernat, Janelle L Gleim, Ryan V Moriarty iD, Alexis J Balgeman, Yonne T de Menezes, Cassaundra L Ameel, Daniel J Fillmore, Skyler M Pergalske, Jennifer A Juno iD und 9 weitere

Infection and Immunity · 2024

DOI: 10.1128/iai.00313-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, 2024. Verfasst von Erica C Larson und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Simian Acquired Immunodeficiency Syndrome, Receptors, Antigen, T-Cell, gamma-delta, Coinfection, Mycobacterium tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, DHAC | National Health and Medical Research Council (NHMRC), ODCDC CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Children living with HIV have a higher risk of developing tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb). Gamma delta (γδ) T cells in the context of HIV/Mtb coinfection have been understudied in children despite in vitro evidence suggesting γδ T cells assist with Mtb control. We investigated whether boosting a specific subset of γδ T cells, phosphoantigen-reactive Vγ9+Vδ2+ cells, could improve TB outcome using a nonhuman primate model of pediatric HIV/Mtb coinfection. Juvenile Mauritian cynomolgus macaques (MCM), equivalent to 4- to 8-year-old children, were infected intravenously (i.v.) with SIV. After 6 months, MCM were coinfected with a low dose of Mtb and then randomized to receive zoledronate (ZOL), a drug that increases phosphoantigen levels, ( n = 5; i.v.) at 3 and 17 days after Mtb accompanied by recombinant human IL-2 (s.c.) for 5 days following each ZOL injection. A similarly coinfected MCM group ( n = 5) was injected with saline as a control. Vγ9+Vδ2+ γδ T cell frequencies spiked in the blood, but not airways, of ZOL+IL-2-treated MCM following the first dose, however, were refractory to the second dose. At necropsy 8 weeks after Mtb, ZOL+IL-2 treatment did not reduce pathology or bacterial burden. γδ T cell subset frequencies in granulomas did not differ between treatment groups. These data show that transiently boosting peripheral γδ T cells with ZOL+IL-2 soon after Mtb coinfection of SIV-infected MCM did not improve Mtb host defense.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Simian Acquired Immunodeficiency SyndromeReceptors, Antigen, T-Cell, gamma-deltaCoinfectionMycobacterium tuberculosisSimian Immunodeficiency VirusAnimalsMacaca fascicularisTuberculosisZoledronic AcidDisease Models, AnimalImidazolesT-LymphocytesT-Lymphocyte Subsets

Stichwörter der Autor:innen

Gamma delta T cellsMycobacterium tuberculosisT cellshuman immunodeficiency virusnonhuman primatespediatric infectious disease

Substanzen

Receptors, Antigen, T-Cell, gamma-deltaZoledronic AcidImidazoles

Autor:innen und Institutionen

  • Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Department of Immunobiology, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
  • Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Pediatrics, UPMC's Children's Hospital of the University of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Erica C Larson, Mark A Rodgers, Ryan V Moriarty, Jennifer A Juno, Stephen J Kent, Lishomwa C Ndhlovu, Shelby L O'Connor, Charles A Scanga

Förderung

  • NIH HHS
  • DHAC | National Health and Medical Research Council (NHMRC)
  • ODCDC CDC HHS
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | Office of AIDS Research

Zitieren

APA

Larson, E. C., Ellis, A. L., Rodgers, M. A., Gubernat, A. K., Gleim, J. L., Moriarty, R. V., Balgeman, A. J., de Menezes, Y. T., Ameel, C. L., Fillmore, D. J., Pergalske, S. M., Juno, J. A., Maiello, P., Chishti, H. B., Lin, P. L., Godfrey, D. I., Kent, S. J., Pellicci, D. G., Ndhlovu, L. C., …, & Scanga, C. A. (2024). Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistance. Infection and Immunity. https://doi.org/10.1128/iai.00313-24

Vancouver

Larson EC, Ellis AL, Rodgers MA, Gubernat AK, Gleim JL, Moriarty RV, et al. Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistance. Infection and Immunity. 2024. doi:10.1128/iai.00313-24

BibTeX
@article{Larson2024,
  author = {Larson, Erica C and Ellis, Amy L and Rodgers, Mark A and Gubernat, Abigail K and Gleim, Janelle L and Moriarty, Ryan V and Balgeman, Alexis J and de Menezes, Yonne T and Ameel, Cassaundra L and Fillmore, Daniel J and Pergalske, Skyler M and Juno, Jennifer A and Maiello, Pauline and Chishti, Harris B and Lin, Philana Ling and Godfrey, Dale I and Kent, Stephen J and Pellicci, Daniel G and Ndhlovu, Lishomwa C and O'Connor, Shelby L and Scanga, Charles A},
  title = {Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistance},
  journal = {Infection and Immunity},
  year = {2024},
  doi = {10.1128/iai.00313-24}
}
Kostenlos starten →